Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2009
11/19/2009WO2009140198A2 Pathogen detection and screening
11/19/2009WO2009140191A2 Detection of disease related gene mutations by single molecule amplification with multiplex ligation assays
11/19/2009WO2009140114A1 Real-time, on-line analysis for the quantification of trihalomethane species within drinking water supplies
11/19/2009WO2009140039A2 Synthetic antibodies
11/19/2009WO2009139928A2 Recombinant chimeric antigens for diagnosis and prevention of scrub typhus
11/19/2009WO2009139919A2 Methods for diagnosis of clostridium diffcile and methods and vectors for recombinant toxin expression
11/19/2009WO2009139913A1 Assay using trpml3 (mcoln3) salty taste receptor and use in identifying taste (salty) modulators
11/19/2009WO2009139889A2 Apparatus and method for optically sensing analyte concentration in an erythrocyte-containing fluid
11/19/2009WO2009139864A2 Fluorescence detection of poison oak oil
11/19/2009WO2009139863A2 Chimeric small molecules for the recruitment of antibodies to cancer cells
11/19/2009WO2009139725A1 Point of care test for the detection of exposure or immunity to dengue virus
11/19/2009WO2009139681A1 Treatment prediction involving hmgcr protei
11/19/2009WO2009139656A1 The alcohol thermal dehydratation chamber, apparatus and method for determination of isotopic composition of non-exchangeable hydrogen and deuterium atoms in ethanol samples
11/19/2009WO2009139632A1 Device and method for separating and analyzing blood
11/19/2009WO2009139407A1 Microanalysis chip adhesive sheet, microanalysis chip, and manufacturing method thereof
11/19/2009WO2009139378A1 Method for quantification of antigen-specific canine or human ige
11/19/2009WO2009139211A1 Device for evaluating degree of degradation of lubricating oil
11/19/2009WO2009139110A1 Intraoral measurement apparatus and intraoral measurement system
11/19/2009WO2009138939A1 A sensor array and a method of manufacturing the same
11/19/2009WO2009138850A1 Hematopoietic cells expressing the protein susd3 and ligands for the protein susd3
11/19/2009WO2009138767A2 Chemical screening
11/19/2009WO2009138760A1 Conductivity sensor device comprising diamond film with at least one nanopore or micropore
11/19/2009WO2009138744A1 Materials and methods relating to a g-protein coupled receptor
11/19/2009WO2009138566A1 Method and equipment for determining dust formation of moving web-like material
11/19/2009WO2009138479A1 System and method for ground material characterization in a grinding system
11/19/2009WO2009138466A2 Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use
11/19/2009WO2009138451A1 Multimarker panel for the differentiation of dilated cardiomyopathy and as basis for a differential therapy and its result
11/19/2009WO2009138408A2 Methods and kits for the diagnosis of rheumatoid arthritis
11/19/2009WO2009138392A1 Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith
11/19/2009WO2009138364A2 Means and methods for predicting renal failure in diabetes patients based on placental growth factor and soluble flt1
11/19/2009WO2009138250A2 Identification of ligand recognition domains
11/19/2009WO2009138229A1 Methods for the identification of parp interacting molecules and for purification of parp proteins
11/19/2009WO2009138130A1 Breast cancer prognostics
11/19/2009WO2009138035A1 Screening method for medicine of blocking cholesterol absorption based on analyzing subcellular localization of npc1l1 protein
11/19/2009WO2009137938A1 High throughput methods of identifying neutral lipid synthases
11/19/2009WO2009137921A1 Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy
11/19/2009WO2009121079A3 Test device and method for testing for vaginal infections
11/19/2009WO2009121031A4 Methods of novel therapeutic candidate identification through gene expression analysis in vascular-related diseases
11/19/2009WO2009119972A3 Highly sensitive bio-sensor, biochip including same and method for manufacturing same
11/19/2009WO2009119971A3 Method for electrically detecting physiologically active materials and biochip for the same
11/19/2009WO2009118205A3 Biomarkers for monitoring or predicting the treatment of cancer
11/19/2009WO2009117683A3 Method and apparatus for analyzing individual cells or particulates using fluorescent quenching and/or bleaching
11/19/2009WO2009117139A3 Dual method for performing in situ hybridization
11/19/2009WO2009115570A3 Method and marker for diagnosis of tubular kidney damage and illnesses
11/19/2009WO2009112701A3 Method for in vitro detection and/or quantification and/or identification of infectious compounds in a biological material
11/19/2009WO2009111757A4 Complete structure elucidation of molecules utilizing single nmr experiment
11/19/2009WO2009110936A3 Antigen retrieval methods for immunohistochemistry
11/19/2009WO2009105562A3 Protein microarrays for mass spectrometry and methods of use therefor
11/19/2009WO2009102957A3 Methods to connect gene set expression profiles to drug sensitivity
11/19/2009WO2009102953A3 Biophysical parameters for systems biology
11/19/2009WO2009102453A3 System and method for quantitative assessment of biological migration behavior
11/19/2009WO2009100201A3 Functionalized platform for arrays configured for optical detection of targets and related arrays, methods and systems
11/19/2009WO2009100131A3 Process to diagnose or treat brain injury
11/19/2009WO2009098272A3 Microfluidic device for assessing object / test material interactions
11/19/2009WO2009097174A3 Electrochemical biosensor
11/19/2009WO2009086398A3 Anti-t. cruzi antibodies and methods of use
11/19/2009WO2009055613A3 Inhibition of urokinase-type plasminogen activator (upa) activity
11/19/2009WO2009049184A9 Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors
11/19/2009WO2009036082A3 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use
11/19/2009WO2009024869A8 Methods and devices for controlled monolayer formation
11/19/2009WO2008148490A8 Hsp27 as biomarker for alzheimer's disease
11/19/2009WO2008147536A8 Methods and compositions for enhancing proteasome activity
11/19/2009WO2008140572A9 Inorganic solids that accelerate coagulation of blood
11/19/2009WO2008119567A8 Cross-species-specific cd3-epsilon binding domain
11/19/2009US20090288176 Novel Gene Disruptions, Compositions and Methods Relating Thereto
11/19/2009US20090287420 Method and system to characterize transcriptionally active regions and quantify sequence abundance for large scale sequencing data
11/19/2009US20090287419 Agglutination judgment method
11/19/2009US20090287313 Tissue adhesive sealant
11/19/2009US20090286858 Assays for modulators of asparaginyl hydroxylase
11/19/2009US20090286856 Method of Diagnosing Breast Cancer
11/19/2009US20090286854 Aptamers directed to muci
11/19/2009US20090286849 Modulation of insulin like growth factor i receptor expression
11/19/2009US20090286720 Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actin
11/19/2009US20090286714 Novel molecules of the card-related protein family and uses thereof
11/19/2009US20090286713 Collagen Receptor I-Domain Binding Modulators
11/19/2009US20090286330 Immunoassay using insoluble carrier particles and reagent therefor
11/19/2009US20090286329 Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
11/19/2009US20090286328 Use of protein s100a12 as a marker for colorectal cancer
11/19/2009US20090286325 Method of detecting target nucleic acid and container used for the detecting method
11/19/2009US20090286324 Serum markers for type ii diabetes mellitus
11/19/2009US20090286316 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
11/19/2009US20090286313 Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
11/19/2009US20090286308 Process for assembling two surfaces or one surface with a molecule of interest
11/19/2009US20090286271 Methods of Diagnosing and Treating Complications of Pregnancy
11/19/2009US20090286269 Method for detecting PrP using at least one positive charge and/or at least one glycosidic bond and a ligand other than a protein ligand
11/19/2009US20090286268 Assays for Cancer Patient Monitoring Based on Levels of Analyte Components of the Plasminogen Activator System in Body Fluid Samples
11/19/2009US20090286267 Methods for Determining Drug Responsiveness
11/19/2009US20090286266 Method of Determining The Sex of Birds, Reptiles and Mammals Using Steroid Hormones
11/19/2009US20090286265 Cripto Blocking Antibodies And Uses Thereof
11/19/2009US20090286264 Imaging of immunomagnetically enriched rare cells
11/19/2009US20090286263 Skin tape stripping: a non-invasive diagnostic strategy for dermal exposure to cytotoxic compounds
11/19/2009US20090286262 Nucleic acid, polypeptide and its use
11/19/2009US20090286261 Method for assaying compounds or agents for ability to displace potent ligands of hematopoietic prostaglandin d synthase
11/19/2009US20090286260 predicting whether a CML (Chronic Myloid Leukemia) patient will respond to cancer treatment with Gleevec
11/19/2009US20090286259 Screening method for gpcr ligands
11/19/2009US20090286258 Analysis of antibody drug conjugates by bead-based affinity capture and mass spectrometry
11/19/2009US20090286257 Water soluble nanocrystalline quantum dots capable of near infrared emissions
11/19/2009US20090286256 Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
11/19/2009US20090286249 Inactivatable target capture oligomers for use in the selective hybridization and capture of target nucleic acid sequences
11/19/2009US20090286237 Diagnostic Kits and Methods for Oesophageal Abnormalities